Diabeloop, a pioneer in therapeutic artificial intelligence for diabetes management, today announces that DBLG2 ...
Introducing continuous glucose monitoring in primary care optimizes diabetes management in underserved populations.
The newly approved over-the-counter CGM offers a new approach to tackling childhood obesity but also raises a host of ...
Continuous glucose monitors have become popular among those who need to track their glucose levels because they're painless ...
Following expanded FDA approval for pediatric patients, the over-the-counter Stelo continuous glucose monitor is adding AI ...
As the Q1 earnings season wraps, let’s dig into this quarter’s best and worst performers in the patient monitoring industry, ...
New research from Montefiore Einstein investigators reveals that an underutilized tool, more commonly employed by ...
FDA clears Dexcom Stelo as the first OTC CGM for children, raising new questions around app access, caregiver oversight, school device rules, and reimbursement.
A new initiative integrated personal continuous glucose monitor reports into routine primary care visits for diabetes.
Smartwatches may transform blood sugar tracking, but today’s advances depend on CGMs, AI, and regulated health tech ...
India Today on MSN
Wearable devices help build healthy habits, but cannot replace doctors
Wearable devices can help track activity, sleep and blood sugar. The data should support, not replace, medical advice and body signals.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results